Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance Ayala Pharmaceuticals stock opened at $0.03 on Wednesday. The firm has a market cap of $1.15 million, a price-to-earnings ratio of […]
StockNews.com Initiates Coverage on Streamline Health Solutions (NASDAQ:STRM)
Investment analysts at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “sell” rating on the stock. Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September […]
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the medical equipment provider’s stock. Separately, HC Wainwright decreased their target price on shares of Aethlon Medical from $10.00 to $7.00 and set a buy rating […]
Titan Pharmaceuticals (NASDAQ:TTNP) Coverage Initiated at StockNews.com
Equities research analysts at StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance TTNP stock opened at $5.00 on Tuesday. Titan Pharmaceuticals has a 52 week […]
MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research note published on Sunday morning. The firm issued a buy rating on the stock. A number of other equities research analysts have also recently issued reports on MEIP. Laidlaw cut MEI Pharma from a buy rating to a hold rating […]
last updated on 12 Oct 08:21